全文获取类型
收费全文 | 497篇 |
免费 | 46篇 |
专业分类
543篇 |
出版年
2024年 | 3篇 |
2022年 | 12篇 |
2021年 | 16篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 7篇 |
2017年 | 6篇 |
2016年 | 31篇 |
2015年 | 23篇 |
2014年 | 23篇 |
2013年 | 26篇 |
2012年 | 27篇 |
2011年 | 29篇 |
2010年 | 25篇 |
2009年 | 20篇 |
2008年 | 34篇 |
2007年 | 25篇 |
2006年 | 20篇 |
2005年 | 21篇 |
2004年 | 19篇 |
2003年 | 10篇 |
2002年 | 9篇 |
2001年 | 8篇 |
2000年 | 8篇 |
1999年 | 4篇 |
1998年 | 3篇 |
1996年 | 3篇 |
1994年 | 3篇 |
1993年 | 5篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1982年 | 3篇 |
1981年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 4篇 |
1976年 | 3篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1972年 | 3篇 |
1969年 | 2篇 |
1962年 | 3篇 |
排序方式: 共有543条查询结果,搜索用时 15 毫秒
541.
Poonam Kumari Ashutosh Kumar Arya Rimesh Pal Ashwani Sood Divya Dahiya Soham Mukherjee Ashu Rastogi Sanjay Kumar Bhadada 《Endocrine practice》2022,28(1):96-101
ObjectiveTo describe the prevalence and compare the clinicobiochemical profile of patients with primary hyperparathyroidism (PHPT) with and without type 2 diabetes mellitus (T2DM).MethodsWe conducted a retrospective observational study wherein the details of patients with PHPT with T2DM (PHPT-T2DM) and without T2DM were retrieved from the Indian PHPT Registry (www.indianphptregistry.com) between 2005 and 2019. We compared the clinical, biochemical, and postoperative findings of patients with PHPT-T2DM with age-, sex-, and body mass index–matched patients with PHPT without T2DM (in 1:2 ratio).ResultsOf the 464 patients with PHPT, 54 (11.6%) had T2DM. We observed an increase in the prevalence of PHPT-T2DM cases over time; only 7 (7.1%) of the total patients with PHPT had T2DM between 2005 and 2009 that increased to 31 (12.8%) in the last half decade (2015-2019). Patients with PHPT-T2DM had a significantly lower prevalence of nephrolithiasis (18.5% vs 36.1%, respectively; P = .03) and a higher prevalence of pancreatitis (22.2% vs 5.6%, respectively; P = .007) than those without T2DM. Furthermore, intact parathyroid hormone (203 pg/mL [139.8-437.3 pg/mL] vs 285 pg/mL [166-692 pg/mL], respectively; P = .04) and serum creatinine (0.90 mg/dL [0.67-1.25 mg/dL] vs 1.10 mg/dL [0.73-1.68 mg/dL], respectively; P = .03) levels were significantly lower in patients with PHPT-T2DM than those without T2DM. Also, tumor weight tended to be lower in patients with PHPT-T2DM than in the non-T2DM counterparts (1.05 g [0.5-2.93 g] vs 2.16 g [0.81-7.0 g], respectively; P = .06).ConclusionThe prevalence of T2DM in Asian Indians with PHPT is 11.6%. Patients with PHPT-T2DM are characterized by a higher prevalence of pancreatitis, a lower prevalence of nephrolithiasis, and lower levels of intact parathyroid hormone/creatinine. Part of the clinical picture can possibly be explained by early detection of PHPT in patients with T2DM consequent to more frequent screening. 相似文献
542.
S N Arya 《Boletín chileno de parasitología》1992,47(1-2):38-39
Kathlania sprentii n. sp. is described from the intestine of a marine fish. Trichiurus muticus (Griffith) from the South coast of Indian Ocean, India. The new form differs from other known species of the genus in the presence of two rounded teeth-like structures in the buccal capsule, spicule ratio 1:4 and rod-shaped gubernaculum with bifurcated distal end. 相似文献
543.
Human immunodeficiency virus type-2 gene expression: two enhancers and their activation by T-cell activators 总被引:5,自引:0,他引:5
S K Arya 《The New biologist》1990,2(1):57-65
The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying potential to infect their host, undergo long periods of latent infection, and induce pathology. Since expression of the viruses is in large part regulated by the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR. The HIV-2 LTR was found to contain two enhancers. One of these enhancers is, in part, identical to the HIV-1 enhancer. This enhancer in HIV-1 is the T-cell activation response element; in HIV-2, however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators. The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation. Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2. 相似文献